199 related articles for article (PubMed ID: 27490982)
1. Correlation of Ki-67 indices from biopsy and resection specimens of neuroendocrine tumours.
Barnes J; Johnson SJ; French JJ
Ann R Coll Surg Engl; 2017 Mar; 99(3):193-197. PubMed ID: 27490982
[TBL] [Abstract][Full Text] [Related]
2. Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?
Rebours V; Cordova J; Couvelard A; Fabre M; Palazzo L; Vullierme MP; Hentic O; Sauvanet A; Aubert A; Bedossa P; Ruszniewski P
Dig Liver Dis; 2015 Nov; 47(11):973-7. PubMed ID: 26169284
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.
Larghi A; Capurso G; Carnuccio A; Ricci R; Alfieri S; Galasso D; Lugli F; Bianchi A; Panzuto F; De Marinis L; Falconi M; Delle Fave G; Doglietto GB; Costamagna G; Rindi G
Gastrointest Endosc; 2012 Sep; 76(3):570-7. PubMed ID: 22898415
[TBL] [Abstract][Full Text] [Related]
4. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
[TBL] [Abstract][Full Text] [Related]
5. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A
World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
7. Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated.
Hwang HS; Kim Y; An S; Kim SJ; Kim JY; Kim SY; Hwang DW; Park DH; Lee SS; Kim SC; Seo DW; Hong SM
Pancreas; 2018; 47(10):1296-1303. PubMed ID: 30211805
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of grading pancreatic neuroendocrine neoplasms with Ki-67 index in fine-needle aspiration cellblock material.
Grosse C; Noack P; Silye R
Cytopathology; 2019 Mar; 30(2):187-193. PubMed ID: 30303569
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.
Weynand B; Borbath I; Bernard V; Sempoux C; Gigot JF; Hubert C; Lannoy V; Deprez PH; Jouret-Mourin A
Cytopathology; 2014 Dec; 25(6):389-95. PubMed ID: 24750272
[TBL] [Abstract][Full Text] [Related]
10. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors.
Laskiewicz L; Jamshed S; Gong Y; Ainechi S; LaFemina J; Wang X
Cancer Cytopathol; 2018 Mar; 126(3):170-178. PubMed ID: 29266776
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
13. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
[TBL] [Abstract][Full Text] [Related]
14. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
[TBL] [Abstract][Full Text] [Related]
15. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
Sugimoto S; Hotta K; Shimoda T; Imai K; Ito S; Yamaguchi Y; Takizawa K; Kakushima N; Tanaka M; Kawata N; Yoshida M; Ishiwatari H; Matsubayashi H; Ono H
Dig Dis; 2018; 36(2):118-122. PubMed ID: 29130971
[TBL] [Abstract][Full Text] [Related]
16. KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
Grillo F; Valle L; Ferone D; Albertelli M; Brisigotti MP; Cittadini G; Vanoli A; Fiocca R; Mastracci L
Endocrine; 2017 Sep; 57(3):494-502. PubMed ID: 28726181
[TBL] [Abstract][Full Text] [Related]
17. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
[No Abstract] [Full Text] [Related]
18. Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection.
Milione M; Maisonneuve P; Pellegrinelli A; Spaggiari P; Centonze G; Coppa J; Delconte G; Droz Dit Busset M; Lanhazo O; Pruneri G; Mazzaferro V
Eur J Surg Oncol; 2019 May; 45(5):755-760. PubMed ID: 30366875
[TBL] [Abstract][Full Text] [Related]
19. Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors.
Richards-Taylor S; Tilley C; Jaynes E; Hu H; Armstrong T; Pearce NW; Plant R; Cave J
Pancreas; 2017; 46(10):1354-1358. PubMed ID: 28984786
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]